MVIS.NASDAQMicrovision, INC

Form 4: MicroVision Director Jada Smith Reports Routine Stock Transactions and New RSU Grant

Sentiment:

Insider Transaction Report


MicroVision, Inc. Director Jada Smith reported the vesting of 20,112 restricted stock units into common stock and the grant of 87,642 new restricted stock units as part of her compensation.

Summary

  • MicroVision, Inc. Director Jada Smith reported changes in her beneficial ownership of company securities.
  • On June 5, 2025, 20,112 restricted stock units (RSUs) vested and converted into an equal number of common shares, without payment.
  • Following this conversion, Ms. Smith's direct beneficial ownership of common stock increased by 20,112 shares, bringing her total direct common stock ownership to 60,337 shares.
  • Concurrently, the 20,112 derivative restricted stock units were disposed of as they converted into common stock, resulting in 0 derivative RSUs from that specific grant.
  • On June 6, 2025, Ms. Smith was granted 87,642 new restricted stock units.
  • These newly granted RSUs are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, contingent on her continued service as a director.

Sentiment

Score: 6

Explanation: The document reports routine insider transactions involving the vesting of existing equity awards and the grant of new ones. This is a standard compensation event for a director, indicating continued alignment of interests and no immediate negative implications for the company. The grant of new RSUs is a positive for director retention and long-term alignment.

Positives

  • Director Jada Smith received 20,112 shares of common stock through the vesting of previously granted restricted stock units, increasing her direct ownership.
  • The grant of 87,642 new restricted stock units aligns the director's interests with long-term shareholder value, incentivizing continued service and performance.

Negatives

  • No negative information is presented in this routine insider transaction report.

Risks

  • The vesting of newly granted restricted stock units is contingent upon the reporting person's continued service as a director through each vesting date, meaning the full benefit is not guaranteed if service ceases.

Future Outlook

The newly granted 87,642 restricted stock units are scheduled to vest in four equal quarterly installments, with full vesting occurring on the earlier of June 6, 2026, or the day prior to MicroVision's 2026 Annual Meeting of Stockholders, provided the director continues her service.

Management Comments

  • Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
  • At vesting, RSUs convert into shares of common stock on a unit-for-share basis, without payment.
  • RSUs granted 06/05/2024 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2025 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date.
  • Each RSU represents a contingent right to receive one share of MicroVision common stock.
  • RSUs granted 06/06/2025 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date.

Industry Context

This Form 4 filing represents a routine insider transaction, common across publicly traded companies, where directors and executives receive equity compensation in the form of restricted stock units that vest over time, aligning their interests with long-term company performance and shareholder value. Such compensation practices are standard in the technology and advanced display industries, where MicroVision operates.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation PolicyThe grant of restricted stock units to Director Jada Smith is part of MicroVision's ongoing equity compensation program for its directors, designed to incentivize long-term service and align interests with shareholders.06/06/2025Reinforces director retention and aligns director's financial interests with the company's long-term performance.

Stakeholder Impact

  • Shareholders: The vesting of RSUs results in a slight increase in outstanding shares (dilution), but the grant of new RSUs aligns the director's interests with long-term shareholder value.

Next Steps

  • Future vesting of the 87,642 restricted stock units granted on June 6, 2025, in four equal quarterly installments.
  • Continued service of Jada Smith as a director of MicroVision, Inc. to ensure full vesting of the new RSUs.

Key Dates

DateDescription
06/05/2024Grant date of the restricted stock units that vested on 06/05/2025.
06/05/2025Date of vesting and conversion of 20,112 restricted stock units into common stock.
06/06/2025Date of grant of 87,642 new restricted stock units and filing date of the Form 4.
2025 Annual MeetingEarlier of which previously granted RSUs would be fully vested.
2026 Annual MeetingEarlier of which newly granted RSUs would be fully vested.

Keywords

MicroVision, MVIS, SEC Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, RSU, Director Compensation, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.